Use of hypertonic saline, clopamide and furosemide for evaluation of the concentrating defect in pitressin-treated diabetes insipidus.
D000577:Amides; D003005:Clopamide; D003919:Diabetes Insipidus / Q000150:complications / Q000188:drug therapy*; D004232:Diuretics; D005260:Female; D005665:Furosemide; D006801:Humans; D006982:Hypertonic Solutions; D007668:Kidney / Q000503:physiopathology*; D007671:Kidney Concentrating Ability; D007674:Kidney Diseases / Q000175:diagnosis*; D008297:Male; D008875:Middle Aged; D010880:Piperidines; D012965:Sodium Chloride; D013634:Tannins / Q000627:therapeutic use; D014667:Vasopressins / Q000627:therapeutic use*
D000577:Amides; D004232:Diuretics; D006982:Hypertonic Solutions; D010880:Piperidines; D013634:Tannins; D014667:Vasopressins; D003005:Clopamide; D012965:Sodium Chloride; D005665:Furosemide